The Wellcome Trust is the world’s second-highest spending charitable foundation, dedicated to achieving extraordinary improvements in human and animal health.
It supports bright minds in biomedical research and the medical humanities, including public engagement, education and the application of research to improve health. It is independent of both political and commercial interests.
The Wellcome Trust has provided funding to Novasang through its Translational Award programme, set up to develop innovative and ground breaking new technologies in the biomedical area.
Projects funded have already demonstrated proof of principle, supported by experimental data, with the plan to take the product, technology or intervention to a stage at which it is sufficiently developed to be attractive to another party.
Translation Awards are designed to be flexible, enabling freedom to innovate and push the boundaries of current knowledge.
The Wellcome Trust’s aim is to support exceptional individuals with the brightest minds through larger and bolder awards to accelerate product development.